Cargando…
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer
BACKGROUND: Metastatic peritoneal carcinomatosis (MPC) is not common in patients with non-small cell lung cancer (NSCLC), and the clinical characteristics and treatment outcomes are still unclear. PATIENTS AND METHODS: We recruited 46 NSCLC patients with MPC at Keio University and affiliated hospita...
Autores principales: | Tani, Tetsuo, Nakachi, Ichiro, Ikemura, Shinnosuke, Nukaga, Shigenari, Ohgino, Keiko, Kuroda, Aoi, Terai, Hideki, Masuzawa, Keita, Shinozaki, Taro, Ishioka, Kota, Funatsu, Yohei, Koh, Hidefumi, Fukunaga, Koichi, Soejima, Kenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487800/ https://www.ncbi.nlm.nih.gov/pubmed/34616179 http://dx.doi.org/10.2147/CMAR.S330103 |
Ejemplares similares
-
Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells
por: Ohgino, Keiko, et al.
Publicado: (2020) -
Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma
por: Takaoka, Hatsuyo, et al.
Publicado: (2022) -
Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations
por: Masuzawa, Keita, et al.
Publicado: (2017) -
Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma
por: Hamamoto, Junko, et al.
Publicado: (2015) -
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer
por: Hirano, Toshiyuki, et al.
Publicado: (2015)